Vir Biotechnology, Inc. (VIR)
Vir Biotechnology Market Cap : 1.455B for April 2, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Hims & Hers Health, Inc. | 4.169B |
| BioMarin Pharmaceutical, Inc. | 10.82B |
| Xeris Biopharma Holdings, Inc. | 1.085B |
| Gossamer Bio, Inc. | 96.69M |
| Sensei Biotherapeutics, Inc. | 43.13M |
Market Cap Related Metrics
| PS Ratio | 18.40 |
| Price to Book Value | 1.901 |
| Price | 9.045 |
| Earnings Yield | -34.75% |